Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation

被引:28
作者
Chulkina, Marina [1 ]
Beswick, Ellen J. [2 ]
Pinchuk, Irina, V [1 ]
机构
[1] Penn State Hlth Milton S Hershey Med Ctr, Dept Med, Hershey, PA 17033 USA
[2] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA
关键词
PD-L1; gastrointestinal inflammation; homeostasis; inflammatory bowel disease; CHECKPOINT INHIBITOR THERAPY; CD4(+) T-CELLS; DEATH LIGAND 1; IFN-GAMMA; INTESTINAL INFLAMMATION; HELICOBACTER-PYLORI; CROHNS-DISEASE; LAMINA PROPRIA; CELIAC-DISEASE; B7; FAMILY;
D O I
10.3390/ijms21239165
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The gastrointestinal (GI) mucosa is among the most complex systems in the body. It has a diverse commensal microbiome challenged continuously by food and microbial components while delivering essential nutrients and defending against pathogens. For these reasons, regulatory cells and receptors are likely to play a central role in maintaining the gut mucosal homeostasis. Recent lessons from cancer immunotherapy point out the critical role of the B7 negative co-stimulator PD-L1 in mucosal homeostasis. In this review, we summarize the current knowledge supporting the critical role of PD-L1 in gastrointestinal mucosal tolerance and how abnormalities in its expression and signaling contribute to gut inflammation and cancers. Abnormal expression of PD-L1 and/or the PD-1/PD-L1 signaling pathways have been observed in the pathology of the GI tract. We also discuss the current gap in our knowledge with regards to PD-L1 signaling in the GI tract under homeostasis and pathology. Finally, we summarize the current understanding of how this pathway is currently targeted to develop novel therapeutic approaches.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 115 条
  • [61] Impaired selection of IgA and intestinal dysbiosis associated with PD-1-deficiency
    Maruya, Mikako
    Kawamoto, Shimpei
    Kato, Lucia M.
    Fagarasan, Sidonia
    [J]. GUT MICROBES, 2013, 4 (02) : 165 - 171
  • [62] Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
    Menzies, A. M.
    Johnson, D. B.
    Ramanujam, S.
    Atkinson, V. G.
    Wong, A. N. M.
    Park, J. J.
    McQuade, J. L.
    Shoushtari, A. N.
    Tsai, K. K.
    Eroglu, Z.
    Klein, O.
    Hassel, J. C.
    Sosman, J. A.
    Guminski, A.
    Sullivan, R. J.
    Ribas, A.
    Carlino, M. S.
    Davies, M. A.
    Sandhu, S. K.
    Long, G. V.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (02) : 368 - 376
  • [63] Modulation of PD-L1 and CD8 Activity in Idiopathic and Infectious Chronic Inflammatory Conditions
    Mezache, Louisa
    Magro, Cynthia
    Hofmeister, Craig
    Pichiorri, Flavia
    Sborov, Douglas
    Nuovo, Gerard J.
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2017, 25 (02) : 100 - 109
  • [64] Inflammation induced PD-L1-specific T cells
    Munir, Shamaila
    Lundsager, Mia Thorup
    Jorgensen, Mia Aabroe
    Hansen, Morten
    Petersen, Trine Hilkjaer
    Bonefeld, Charlotte Menne
    Friese, Christina
    Met, Ozcan
    Straten, Per Thor
    Andersen, Mads Hald
    [J]. CELL STRESS, 2019, 3 (10) : 319 - 327
  • [65] The expression and function of costimulatory molecules B7h and B7-H1 on colonic epithelial cells
    Nakazawa, A
    Dotan, I
    Brimnes, J
    Allez, M
    Shao, L
    Tsushima, F
    Azuma, M
    Mayer, L
    [J]. GASTROENTEROLOGY, 2004, 126 (05) : 1347 - 1357
  • [66] Current and emerging therapeutic targets for IBD
    Neurath, Markus F.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (05) : 269 - 278
  • [67] Cytokines in inflammatory bowel disease
    Neurath, Markus F.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2014, 14 (05) : 329 - 342
  • [68] PD-1/PD-L1 Pathway Mediates the Alleviation of Pulmonary Fibrosis by Human Mesenchymal Stem Cells in Humanized Mice
    Ni, Ke
    Liu, Ming
    Zheng, Jian
    Wen, Liyan
    Chen, Qingyun
    Xiang, Zheng
    Lam, Kowk-Tai
    Liu, Yinping
    Chan, Godfrey Chi-Fung
    Lau, Yu-Lung
    Tu, Wenwei
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2018, 58 (06) : 684 - 695
  • [69] Genetic variation and expression levels of tight junction genes identifies association between MAGI3 and inflammatory bowel disease
    Noren, Elisabeth
    Almer, Sven
    Soderman, Jan
    [J]. BMC GASTROENTEROLOGY, 2017, 17
  • [70] Stromal Cell PD-L1 Inhibits CD8+ T-cell Antitumor Immune Responses and Promotes Colon Cancer
    O'Malley, Grace
    Treacy, Oliver
    Lynch, Kevin
    Naicker, Serika D.
    Leonard, Niamh A.
    Lohan, Paul
    Dunne, Philip D.
    Ritter, Thomas
    Egan, Laurence J.
    Ryan, Aideen E.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2018, 6 (11) : 1426 - 1441